SLPI suppresses hepatocellular carcinoma progression via endoplasmic reticulum stress induced apoptosis

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Secretory leukocyte protease inhibitor (SLPI) has been reported to function as a regulatory factor in several cancers. However, its biological functions and underlying mechanisms in HCC remain to be uncovered. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Li, Jinfan, Wu, Zhen, Liang, Yuwan, Duan, Rong, Zheng, Mengsha, Wang, Jing, Kong, Derun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692157/
https://www.ncbi.nlm.nih.gov/pubmed/34975323
http://dx.doi.org/10.7150/ijbs.65676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692157/
https://www.ncbi.nlm.nih.gov/pubmed/34975323
http://dx.doi.org/10.7150/ijbs.65676

Ejemplares similares